Viral Outbreaks and Epidemiology

Recent Advances in Drug Discovery

The worldwide business sector for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% somewhere around 2012 and 2017. Another report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015.

Drug-drug interactions occur when a drug interacts, or interferes, with another drug modify the way one or both of the drugs act in the body, or cause unexpected side effects. The drugs involved can be prescription medications, over-the-counter medicines and even vitamins and natural products.

Relevant Conferences:

2nd International Conference and Expo on Drug Discovery & Designing, November 08-09, 2016 Istanbul, Turkey; Structure Based Drug Design Conference, February 21–24, 2016, USA; 8th International Conference and Exhibition on Pharmaceutics and Novel Drug Delivery Systems March 07-09, 2016, Spain; 11th Annual Fragment-Based Drug Discovery, April 20-21, 2016, USA; Drug Discovery and Therapy World Congress May 11-14, 2016, USA; 4th Annual conferences on European Pharma Congress June 13-15, 2016, Germany; 9th World Drug Delivery Summit June 30-July 02, 2016, USA; 7th International conference and exhibition onPharmacovigilance and Clinical Trials September 19-21, 2016, Austria; International Conference and Expo onGeneric Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016, Spain. International Society for Antiviral Research (ISAR), International Society for NeuroVirology, European Society for Clinical Virology (ESCV),Swedish Society of Medical Microbiology.